In our current analysis, we found that addition of NT-proBNP improved prediction of CV events compared with the JADE risk model, which was developed specifically in a similar population of Chinese individuals with type 2 diabetes, with significant improvement as demonstrated by improvement in ROC, NRI and IDI. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.